Table 2

Pathogenic ATM germline changes in families with breast cancer, sporadic breast cancer, and controls

Family IDPhenotype*Exonnt changeSporadic breast cancerControls
Br, breast; Bs, basal cell; Bt, brain; Csu, cancer site unknown; Pan, pancreas; Pro, prostate; Pul, pulmonary; Sar, sarcoma; Sto, stomach; Th, thyroid.
*The mutation status has not been defined for all subjects.
†Initially studied probands.
‡Patients subsequently tested positive for BRCA2 mutation 5797G>T.
003Br(50)†, Br(59), Br(51), Th(47), Pro(59), Br (71), Sto, Pul (55), Csu537522G>C0/850/200
005Br(57)+Sto(41)†, Bs(70), Sto, Sto, Sto(41), Csu, Th(55)537522G>C0/850/200
004Br(50)†, Br(47)+Sar(18)†, Br(40)†, Sto, Bt, Pan(40), Br(54), Sto, Pan, Br(45)‡, Br(37)‡, Bt, Sto, Sto, Br(30), Bt, Pro, Sto496903insA0/850/200